Literature DB >> 34427314

Musculoskeletal Pain in Patients with Psoriasis and its Influence on Health-related Quality of Life: Results from a Danish Population-based Survey.

Sara Kamp Felbo1, Lene Terslev, Inge Juul Sørensen, Lone Skov, Claus Zachariae, Mikkel Østergaard.   

Abstract

This study used a nationwide e-based survey of patients with psoriasis to assess the pattern of musculoskeletal pain and its influence on patient-reported outcomes, including health-related quality of life and disability. A total of 561 respondents (56% of the screened psoriasis patients) reported physician-diagnosed psoriasis and completed the questionnaire. Respondents were grouped based on the presence of musculoskeletal pain and/or diagnosed psoriatic arthritis: 81% had psoriasis without arthritis (29% pain now, 23% pain previously, 39% no pain ever), and 19% had psoriatic arthritis. Patients with psoriasis with pain now had poorer quality of life compared with patients without pain and, importantly, similar to that of patients with arthritis. Furthermore, patients with pain now/previously reported higher self-assessed severity of psoriasis and lower satisfaction with current treatment than patients without pain. Two-thirds of patients with psoriasis with pain now/previously and one-third of patients with arthritis had never been examined by a rheumatologist, demonstrating an unmet need for adequate evaluation of such patients. A nationwide e-based survey of patients with psoriasis was preformed to assess the pattern of musculoskeletal pain and its influence on patient-reported outcomes, including health-related quality of life and disability. A total of 561 respondents (56% of the screened psoriasis patients) reported physician- diagnosed psoriasis and completed the questionnaire. Respondents were grouped based on the presence of musculoskeletal pain and/or diagnosed psoriatic arthritis: 81% had psoriasis without arthritis (29% pain now, 23% pain previously, 39% no pain ever), and 19% had psoriatic arthritis. Patients with psoriasis with pain now had poorer quality of life compared with patients without pain and, importantly, similar to that of patients with arthritis. Furthermore, patients with pain now/previously reported higher self-assessed severity of psoriasis and lower satisfaction with current treatment than patients without pain. Two-thirds of patients with psoriasis with pain now/previously and one-third of patients with arthritis had never been examined by a rheumatologist, demonstrating an unmet need for adequate evaluation of such patients.

Entities:  

Keywords:  musculoskeletal pain; psoriatic arthritis; quality of life; survey; psoriasis

Mesh:

Year:  2021        PMID: 34427314      PMCID: PMC9425568          DOI: 10.2340/00015555-3906

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   3.875


  22 in total

1.  High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires.

Authors:  Muhammad Haroon; Brian Kirby; Oliver FitzGerald
Journal:  Ann Rheum Dis       Date:  2012-06-23       Impact factor: 19.103

2.  Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use.

Authors:  A Y Finlay; G K Khan
Journal:  Clin Exp Dermatol       Date:  1994-05       Impact factor: 3.470

3.  Quality of life and prevalence of arthritis reported by 5,795 members of the Nordic Psoriasis Associations. Data from the Nordic Quality of Life Study.

Authors:  Hugh Zachariae; Robert Zachariae; Kirsti Blomqvist; Steingrimur Davidsson; Lars Molin; Cato Mørk; Bardur Sigurgeirsson
Journal:  Acta Derm Venereol       Date:  2002       Impact factor: 4.437

4.  Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis.

Authors:  K Reich; K Krüger; R Mössner; M Augustin
Journal:  Br J Dermatol       Date:  2009-02-04       Impact factor: 9.302

5.  Patient perspectives in the management of psoriasis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey.

Authors:  Mark G Lebwohl; Hervé Bachelez; Jonathan Barker; Giampiero Girolomoni; Arthur Kavanaugh; Richard G Langley; Carle F Paul; Lluís Puig; Kristian Reich; Peter C M van de Kerkhof
Journal:  J Am Acad Dermatol       Date:  2014-02-24       Impact factor: 11.527

6.  The prevalence of psoriatic arthritis in people with psoriasis.

Authors:  G Ibrahim; R Waxman; P S Helliwell
Journal:  Arthritis Rheum       Date:  2009-10-15

7.  Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L).

Authors:  M Herdman; C Gudex; A Lloyd; Mf Janssen; P Kind; D Parkin; G Bonsel; X Badia
Journal:  Qual Life Res       Date:  2011-04-09       Impact factor: 4.147

8.  Comparison of health-related quality of life in rheumatoid arthritis, psoriatic arthritis and psoriasis and effects of etanercept treatment.

Authors:  Vibeke Strand; Veronika Sharp; Andrew S Koenig; Grace Park; Yifei Shi; Brian Wang; Debra J Zack; David Fiorentino
Journal:  Ann Rheum Dis       Date:  2012-01-17       Impact factor: 19.103

9.  Quality of life and contact with healthcare systems among patients with psoriasis and psoriatic arthritis: results from the NORdic PAtient survey of Psoriasis and Psoriatic arthritis (NORPAPP).

Authors:  A Duvetorp; M Østergaard; L Skov; O Seifert; K S Tveit; K Danielsen; Lars Iversen
Journal:  Arch Dermatol Res       Date:  2019-03-13       Impact factor: 3.017

10.  Treatment use and satisfaction among patients with psoriasis and psoriatic arthritis: results from the NORdic PAtient survey of Psoriasis and Psoriatic arthritis (NORPAPP).

Authors:  K S Tveit; A Duvetorp; M Østergaard; L Skov; K Danielsen; L Iversen; O Seifert
Journal:  J Eur Acad Dermatol Venereol       Date:  2018-11-28       Impact factor: 6.166

View more
  1 in total

Review 1.  Exploring the Diverse Immune and Genetic Landscape of Psoriatic Arthritis.

Authors:  Bogdan Batko
Journal:  J Clin Med       Date:  2021-12-17       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.